Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 06/13/2016 - 04/18/2019

Target Audience

This course is designed for pharmacists, nurse practitioners or other healthcare professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Attention-deficit/ hyperactivity disorder (ADHD) is the most commonly diagnosed childhood disorder. Between 1995 and 2008, stimulants prescribed to treat ADHD increased six-fold among adults in the United States. While these medications are the most effective pharmacotherapy treatment for ADHD, there are risks and cautions associated with use. 

Pharmaceutical stimulants, similar to illicit psychostimulants, have the potential to induce abuse and dependence. This session will address the increase in reports related to stimulant misuse, abuse, and diversion within ADHD.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • If necessary, complete the post-test retest no later than the closing activity date. (login first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.

Participants in this course must complete an examination and achieve a score of 70% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.

Faculty Information and Disclosures

Learning Objectives

  1. Compare the prevalence of stimulant abuse, misuse, and nonmedical use in patients with attention-deficit/hyperactivity disorder and the general population.
  2. Select medication for the treatment of attention-deficit/ hyperactivity disorder with a lower risk of nonmedical use.
  3. Construct a treatment plan to monitor patients with attention-deficit/hyperactivity disorder for misuse of stimulant medications.

Continuing Education Credit and Disclosures

Activity Dates: 06/13/2016 - 04/18/2019
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-16-004-H01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.1 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-0000-16-004-H01-P (1.0 contact hours).